- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 405/12 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Patent holdings for IPC class C07D 405/12
Total number of patents in this class: 8035
10-year publication summary
|
671
|
654
|
593
|
626
|
611
|
603
|
572
|
560
|
578
|
139
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1581 |
170 |
| Bristol-myers Squibb Company | 5080 |
130 |
| Boehringer Ingelheim International GmbH | 4629 |
117 |
| Epizyme, Inc. | 383 |
108 |
| Janssen Pharmaceutica N.V. | 3839 |
98 |
| Takeda Pharmaceutical Company Limited | 2961 |
98 |
| AstraZeneca AB | 3042 |
89 |
| Novartis AG | 11238 |
86 |
| F. Hoffmann-La Roche AG | 7958 |
86 |
| Merck Patent GmbH | 5909 |
82 |
| Merck Sharp & Dohme LLC | 3689 |
71 |
| Bayer Cropscience AG | 2241 |
70 |
| The Regents of the University of California | 18943 |
56 |
| Idemitsu Kosan Co., Ltd. | 3995 |
55 |
| Bayer AG | 3045 |
54 |
| Astellas Pharma Inc. | 1145 |
50 |
| Syngenta Participations AG | 4970 |
48 |
| Abbvie Inc. | 1808 |
47 |
| Pfizer Inc. | 3322 |
45 |
| Allergan, Inc. | 2600 |
45 |
| Other owners | 6430 |